DWI阴性脑卒中,溶栓还是不溶?

2020-01-16 Dorothy 医学界神经病学频道

在脑组织缺血的几分钟后,DWI上就可呈现高信号,每个神经内科医生都对这白花花的一片无比熟悉了。

在脑组织缺血的几分钟后,DWI上就可呈现高信号,每个神经内科医生都对这白花花的一片无比熟悉了。

可是,总有一些病史、体征、CT检查和实验室检查结果都高度符合急性缺血性卒中的患者,DWI检查却根本没有阳性结果!

DWI阴性的脑卒中特点如何?什么时候DWI阳性率最高?DWI阴性卒中发生率怎样?哪些卒中容易DWI阴性?DWI阴性,溶栓还是不溶?我们一起来扒一扒。

01
卒中后,DWI信号怎么变化?

表观扩散系数(ADC)反映组织内的水分子弥散运动。DWI信号除了受ADC影响,还受T2透过效应影响,DWI高信号、ADC低信号真正反应水分子移动受限,也即低灌注。

Eastwood等研究发现,急性缺血性卒中病灶的DWI信号强度随时间而演变。平均在卒中后40小时信号最强,至57天恢复正常[1]。DWI和ADC在急性缺血性卒中后的演变规律如下:

急性期(0-7天)

ADC值降低,在1 ~ 4天达到高峰;
DWI上显著高信号,ADC图像上低信号;
可以发生早期DWI逆转(又称弥散性病变逆转),也即DWI高信号的消失。最常见原因是再灌注。但一般是一过性的,DWI异常信号会重新出现,可能是一种“假性逆转”。


DWI:急性期


ADC:急性期

亚急性(1 - 3周)[2]

ADC假性正常化,一般发生在第2周(7-15天)。ADC值上升并回到基线附近,尽管ADC值正常,但仍存在不可逆组织坏死 。由于T2透过效应,DWI仍然保持高信号;
2周后ADC值继续升高,高于正常间质,该区域出现高信号。


(DWI 亚急性期)


(ADC 亚急性期)

慢性期(> 3周)[3]

ADC高信号;
DWI信号多样,但随着时间的推移,信号逐渐下降。

02
DWI阴性卒中,常见吗?

一项2017年发表在Neurology上的Meta分析纳入了 3,236 例急性缺血性卒中的病人,分析了DWI阴性卒中的发病率和临床特点。

结果发现,DWI阴性卒中占所有缺血性卒中的比例是 6.8%(95% 置信区间 (CI) 4.9-9.3)。后循环缺血性卒中的病人,DWI阴性的发生率是前循环缺血的5倍[4]。

一项2015年发表于Stroke杂志的前瞻性研究纳入 264 名非致残性缺血性卒中患者,发病后四天内均进行了 DWI 检查,结果发现28%患者 (95%CI, 23%-35%)均为DWI阴性[5]。

03
DWI阴性脑卒中,溶还是不溶?

急性缺血性卒中仍然是临床诊断,即使初始DWI扫描为阴性,也应考虑紧急再灌注治疗。

2015年,首都医科大学天坛医院的杜万良教授等曾在《中国卒中杂志》上发表了一项回顾性研究的结果,对DWI阴性疑似急性缺血性卒中患者的临床特点进行了研究[6]。

在这项研究中,如患者到达急诊发病时间超过2h或预期不能在3h内用药,即接受多模式MRI检查;部分怀疑急性缺血性卒中的患者经多模式MRI检查时,如溶栓医生判读为DWI阴性,有时会据此排除急性缺血性卒中的诊断而未予溶栓。

该研究最终纳入134例疑似急性缺血性卒中患者,这些患者由溶栓医生初步判断为DWI阴性而未溶栓。其中33例住院进一步诊治。这33例患者中最终有27例诊断为急性缺血性卒中。

DWI阴性的急性缺血性卒中患者有如下特点:NIHSS分值低,症状轻,多为小卒中。

杜万良教授等认为:

DWI阴性的疑似急性缺血性卒中患者,溶栓医生在考虑其他诊断的同时,应尽量避免延误溶栓。DWI阴性的疑似急性缺血性卒中患者并非没有不匹配,而是有可能存在完全不匹配,溶栓医生更需要根据DWI-PWI不匹配或临床-影像不匹配做出溶栓决策。

在这些患者中,虽然DWI阴性,PWI和MRA仍属必要,可以筛选出一部分有明显低灌注或大动脉粥样硬化性闭塞/狭窄、加重风险大而适合溶栓的患者。

如果临床表现高度疑似急性缺血性卒中,即使DWI、PWI和MRA均正常,也不能轻易排除急性缺血性卒中,同样有可能存在完全不匹配。

另外,这134例患者中有20例重新读片后也发现了小的缺血灶。这些病灶通常较小且显影浅淡,提示溶栓医生在阅读DWI影像时要积累经验,提高读片能力。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=882663, encodeId=6fd98826637f, content=挺实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22da5411913, createdName=ms4000000794569408, createdTime=Fri Sep 04 10:18:05 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378602, encodeId=ca093e860287, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3575265725, createdName=不锈钢猪鸡, createdTime=Tue Jan 28 22:46:47 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278718, encodeId=2bf812e871808, content=<a href='/topic/show?id=c3026349f4' target=_blank style='color:#2F92EE;'>#DWI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6349, encryptionId=c3026349f4, topicName=DWI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d40148, createdName=hyf028, createdTime=Sat Jan 18 00:43:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378236, encodeId=f4373e823672, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bd72213756, createdName=120def22m49(暂无昵称), createdTime=Fri Jan 17 09:21:37 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026539, encodeId=3311102653943, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Jan 16 12:43:00 CST 2020, time=2020-01-16, status=1, ipAttribution=)]
    2020-09-04 ms4000000794569408

    挺实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=882663, encodeId=6fd98826637f, content=挺实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22da5411913, createdName=ms4000000794569408, createdTime=Fri Sep 04 10:18:05 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378602, encodeId=ca093e860287, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3575265725, createdName=不锈钢猪鸡, createdTime=Tue Jan 28 22:46:47 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278718, encodeId=2bf812e871808, content=<a href='/topic/show?id=c3026349f4' target=_blank style='color:#2F92EE;'>#DWI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6349, encryptionId=c3026349f4, topicName=DWI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d40148, createdName=hyf028, createdTime=Sat Jan 18 00:43:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378236, encodeId=f4373e823672, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bd72213756, createdName=120def22m49(暂无昵称), createdTime=Fri Jan 17 09:21:37 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026539, encodeId=3311102653943, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Jan 16 12:43:00 CST 2020, time=2020-01-16, status=1, ipAttribution=)]
    2020-01-28 不锈钢猪鸡

    ok

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=882663, encodeId=6fd98826637f, content=挺实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22da5411913, createdName=ms4000000794569408, createdTime=Fri Sep 04 10:18:05 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378602, encodeId=ca093e860287, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3575265725, createdName=不锈钢猪鸡, createdTime=Tue Jan 28 22:46:47 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278718, encodeId=2bf812e871808, content=<a href='/topic/show?id=c3026349f4' target=_blank style='color:#2F92EE;'>#DWI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6349, encryptionId=c3026349f4, topicName=DWI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d40148, createdName=hyf028, createdTime=Sat Jan 18 00:43:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378236, encodeId=f4373e823672, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bd72213756, createdName=120def22m49(暂无昵称), createdTime=Fri Jan 17 09:21:37 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026539, encodeId=3311102653943, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Jan 16 12:43:00 CST 2020, time=2020-01-16, status=1, ipAttribution=)]
    2020-01-18 hyf028
  4. [GetPortalCommentsPageByObjectIdResponse(id=882663, encodeId=6fd98826637f, content=挺实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22da5411913, createdName=ms4000000794569408, createdTime=Fri Sep 04 10:18:05 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378602, encodeId=ca093e860287, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3575265725, createdName=不锈钢猪鸡, createdTime=Tue Jan 28 22:46:47 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278718, encodeId=2bf812e871808, content=<a href='/topic/show?id=c3026349f4' target=_blank style='color:#2F92EE;'>#DWI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6349, encryptionId=c3026349f4, topicName=DWI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d40148, createdName=hyf028, createdTime=Sat Jan 18 00:43:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378236, encodeId=f4373e823672, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bd72213756, createdName=120def22m49(暂无昵称), createdTime=Fri Jan 17 09:21:37 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026539, encodeId=3311102653943, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Jan 16 12:43:00 CST 2020, time=2020-01-16, status=1, ipAttribution=)]
    2020-01-17 120def22m49(暂无昵称)

    厉害

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=882663, encodeId=6fd98826637f, content=挺实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22da5411913, createdName=ms4000000794569408, createdTime=Fri Sep 04 10:18:05 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378602, encodeId=ca093e860287, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3575265725, createdName=不锈钢猪鸡, createdTime=Tue Jan 28 22:46:47 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278718, encodeId=2bf812e871808, content=<a href='/topic/show?id=c3026349f4' target=_blank style='color:#2F92EE;'>#DWI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6349, encryptionId=c3026349f4, topicName=DWI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d40148, createdName=hyf028, createdTime=Sat Jan 18 00:43:00 CST 2020, time=2020-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378236, encodeId=f4373e823672, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bd72213756, createdName=120def22m49(暂无昵称), createdTime=Fri Jan 17 09:21:37 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026539, encodeId=3311102653943, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Jan 16 12:43:00 CST 2020, time=2020-01-16, status=1, ipAttribution=)]
    2020-01-16 健健

    卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!

    0

相关资讯

Stroke:脑卒中后降压处方的差异

由此可见,卒中后开出降压药的处方因医院而异,并取决于患者因素,包括年龄、性别、卒中严重程度和合并症。

加拿大研究:首次卒中后患者30天内新发心脏病风险升高20多倍

卒中杂志发表的一项加拿大研究发现,首次卒中患者30天内新发心脏病风险升高20多倍。研究纳入93627名≥66岁老年受试者,均没有心脏病。21 931名首次缺血性卒中的受试者与71 696名无卒中的受试者进行倾向匹配。研究发现,首次缺血性卒中与不良心血管事件的风险增加相关,且呈时间依赖性。首次卒中后30天之后发生不良心血管事件(包括:急性冠脉综合征、心肌梗死、冠心病、冠状动脉重建术、心力衰竭或心血管

Circulation脑卒中后“寻找房颤”白皮书:缺血性中风或TIA患者应进行72小时心电监测

将近1/3脑卒中是由房颤引起,部分脑卒中是房颤首发临床表现。近日Circulation发表了国际联盟房颤筛查白皮书,专门就脑卒中后房颤的监测提出了指导意见,并提出九大要点。

中美学者研究称,原因不明脑卒中患者,置入式心电监测器可帮助发现房颤

不明原因脑卒中在人群中并不少见。近期一项由美国明尼苏达大学退役军人中心医院李剑明、清华大学临床医院李延辉等进行的研究表明,在普通心电图、Holter 等常规检测手段未能检查房颤的原因不明脑卒中患者中,新一代插入式心电监测器对房颤的检出率为21.7%。即新一代入式心电监测器安全且能有效识别房颤,但识别房颤的准确性有待提高。研究者指出,其在原因不明性脑卒中患者中的应用价值有待于更多的临床研究来证实。这

Neurology:脑卒中后治疗和预后方面的性别差异

由此可见,该分析表明缺血性卒中女性存活率更高,但残疾程度也更高,生活质量较差。住院和院外治疗的差异可能部分解释了这种差异。

沃比医疗与德国Phenox达成全面商业化合作,惠及全球脑卒中患者

12月9日,上海沃比医疗科技有限公司(Wallaby Medical, Inc.)与德国Phenox公司共同宣布,双方签署了商业化战略合作协议,由Phenox在美国和欧洲独家代理沃比医疗Avenir™弹簧圈销售业务。